Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: Correlation with disease activity

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 433-437

  Eijsbouts, Agnes M M ^a   Van Den Hoogen, F H J ^a   Laan, R F J M ^a   Sweep, C G J ^a   Hermus, A R M M ^a   Van De Putte, L B A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROLACTIN; SALAZOSULFAPYRIDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DRUG EFFECT; DRUG UTILIZATION; FEMALE; HORMONE ACTION; HUMAN; HYPOGLYCEMIA; INSULIN TOLERANCE TEST; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STRESS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; MIDDLE AGED; PROLACTIN; SEVERITY OF ILLNESS INDEX; STRESS;

EID: 14144253441     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.001347     Document Type: Article

References (32)

1. Jam LJ, Lavalle C, Fraga A, Gómez-Sanchez C, Silveira LH, Martinez-Osuna P, et al. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 1991;20:273-84.
2. Chikanza IC. Neuroendocrine immunology of RA. Baillieres Clin Rheumatol 1996;10:273-93.
3. Chikanza IC, Grossman AB. Neuroendocrine immune loop. Baillieres Clin Rheumatol 1996;10:199-225.
4. Chikanza IC. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci 1999;876:119-30.
5. Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. Br J Rheumatol 1993;32:445-8.
6. Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994;37:808-13.
7. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-8.
8. Jorgensen C, Bressot N, Bologna C, Sany J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol 1995;22:1829-33.
9. Jorgensen C, Maziad H, Bologna C, Sany J. Kinetics of prolactin release in rheumatoid arthritis. Clin Exp Rheumatol 1995;13:705-9.
10. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol 1998;25:2077-82.
11. Cutolo M, Balleari E, Giusti M, Monochesi M, Accardo S. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol 1986;13:1019-23.
12. Berezi I, Cosby H, Hunter T, Baragar F, McNeilly AS, Friesen HG. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Br J Rheumatol 1987;26:433-6.
13. Nagy E, Chalmers IM, Baragar FD, Friesen HG, Berezi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991;18:1662-8.
14. Gudbjörnsson B, Skogseid B, Öberg K, Wide L, Hällgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol 1996;23:596-602.
15. Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988;31:1314-17.
16. Folomeev M, Prokaeva T, Nassonova V, Nassonov E, Masenko V, Ovtraht N. Prolactin levels in men with SLE and RA. J Rheumatol 1990;17:1569-70.
17. Hedman M, Nilsson E, de la Torre B. Low blood and synovial fluid levels of sulpha-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 1992;10:25-30.
18. Templ E, Koeller M, Riedl M, Wagner O, Graninger W, Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 1996;35:350-6.
19. Eijsbouts A, van den Hoogen F, Loan R, de Waal Malefijt M, Hermus A, Sweep C, et al. Similar response of adrenocorticotrophic hormone, cortisol and prolactin to surgery in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1998;37:1138-9.
20. Gutiérrez MA, Garcia ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycaemia stress test and prolactin stimulation. J Rheumatol 1999;26:277-81.
21. Caviezel F, Catteneo AG, Tell A, Corino T, Mascherpa M. The effect of acetylsalicylic acid and diclofenac on stimulated growth hormone and prolactin secretion in humans. Int J Clin Pharmacol Ther Toxicol 1983;21:502-4.
22. Toppozada M, Gerges F, Khalil H, Marzouk S, Kholeif A. Effect of prostaglandin E2 or prostaglandin synthesis inhibitors on human gonadotrophins and prolactin. Eicosanoids 1992;5:23-7.
23. Joris J, Reuter AM, Vrindts-Gevaert Y, Gathy-Meuleman R, Hargreaves K, Franchimont P. Effect of diclofenac on plasma levels of immunoreactive prolactin, follicle stimulating hormone, luteinizing hormone, thyrotropin, and beta-endorphin in humans. Horm Res 1988;29:143-6.
24. Golub MS, Sowers JR, Eggena P, Baron SH. Effect of prostaglandin inhibition on the prolactin, renin, and aldosterone responses to dopamine antagonism. Metabolism 1982;31:740-3.
25. Masturzo P, Barreca T, Gallamini A, Gianrossi R, Murialdo G, Nizzo MC. Unchanged thyrotropin and prolactin responses to thyrotropin releasing hormone after indomethacin treatment. J Endocrinol Invest 1978;1:167-70.
26. Dussault JH, Turcotte R, Guyda H. The effect of acetylsalicylic acid on TSH and PRL secretion after TRH stimulation in the human. J Clin Endocrinol Metab 1976;43:232-5.
27. Dinan TG, Scott LV, Thakore J, Naesdal J, Keeling PW. Impact of cortisol on buspirone stimulated prolactin release: a double blind placebo-controlled study. Psychoneuroendocrinology 2001;26:751-6.
28. Amett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
29. Van der Heijde DMFM, van't Hof MA, van Riel PLCM, Theunisse LM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practise in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
30. Kremer JAM, Borm G, Schellekens LA, Thomas CMG, Rolland R. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone. J Clin Endocrinol Metab 1991;72:294-300.
31. Pool AJ, Whipp BJ, Skasick AJ, Alavi A, Bland JM, Axford JS. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology 2004;43:43-8.
32. Schettini G, Florio T, Meucci O, et al. Interleukin-1 modulation of prolactin secretion from rat anterior pituitary cells: Involvement of adenylate cyclase activity and calcium mobilization. Endocrinology 1990;126:1435-41.